PMID: 9,685,390
As obesity treatment evolves beyond weight loss alone, Regenerons trevogrumab aims to redefine success by targeting muscle preservation alongside fat reduction
Diabetes Care 34(Suppl 2):S279SS84 Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B et al (2011) Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes
On the other hand, AMPK can phosphorylate GAPDH which, once phosphorylated, is translocated to the nucleus where is able to inhibit DBC1, an SIRT1 endogenous inhibitor, increasing activated SIRT1 levels
Neuroscientist 2017;23:587-604